A role for the long noncoding RNA SENCR in commitment and function of endothelial cells

Molecular Therapy

Volumn 24, Issue 5, 2016, Pages 978-990

  Boulberdaa, Mounia ^a,b   Scott, Elizabeth ^a   Ballantyne, Margaret ^a   Garcia, Raquel ^a   Descamps, Betty ^c   Angelini, Gianni D ^c,d   Brittan, Mairi ^b   Hunter, Amanda ^b   McBride, Martin ^a   McClure, John ^a   Miano, Joseph M ^e   Emanueli, Costanza ^c,d   Mills, Nicholas L ^b   Mountford, Joanne C ^a,f   Baker, Andrew H ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; LONG NONCODING RNA SENCR, HUMAN;

ANGIOGENESIS; ARTICLE; BRACHYURY GENE; CELL DIFFERENTIATION; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOPLASM; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLI GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MESODERM; MIXL1 GENE; NANOG GENE; OCT4 GENE; PHENOTYPE; SENCR GENE; SOX2 GENE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84962703776     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2016.41     Document Type: Article

References (44)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
2. Evseenko D, Zhu Y, Schenke-Layland K, Kuo J, Latour B, Ge S, et al. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 107: 13742-13747.
3. Flamme I, Frolich T and Risau W (1997). Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173: 206-210.
4. Descamps B and Emanueli C (2012). Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol 56: 267-279.
5. Kane NM, Thrasher AJ, Angelini GD and Emanueli C (2014). Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells 32: 1059-1066.
6. Wapinski O and Chang HY (2011). Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361.
7. Fatica A and Bozzoni I (2014). Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15: 7-21.
8. Grote P, Wittler L, Hendrix D, Koch F, Währisch S, Beisaw A, et al. (2013). The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell 24: 206-214.
9. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, et al. (2013). Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 152: 570-583.
10. Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, et al. (2010). A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115: 133-139.
11. Kurian L, Aguirre A, Sancho-Martinez I, Benner C, Hishida T, Nguyen TB, et al. (2015). Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation 131: 1278-1290.
12. Bell RD, Long X, Lin M, Bergmann JH, Nanda V, Cowan SL, et al. (2014). Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol 34: 1249-1259.
13. De Val S and Black BL (2009). Transcriptional control of endothelial cell development. Dev Cell 16: 180-195.
14. Padrón-Barthe L, Temiño S, Villa del Campo C, Carramolino L, Isern J and Torres M (2014). Clonal analysis identifies hemogenic endothelium as the source of the bloodendothelial common lineage in the mouse embryo. Blood 124: 2523-2532.
15. Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F, et al. (2012). Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep 2: 553-567.
16. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, et al. (2014). Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114: 1389-1397.
17. Abedin MJ, Nguyen A, Jiang N, Perry CE, Shelton JM, Watson DK, et al. (2014). Fli1 acts downstream of Etv2 to govern cell survival and vascular homeostasis via positive autoregulation. Circ Res 114: 1690-1699.
18. Arnold SJ and Robertson EJ (2009). Making a commitment: cell lineage allocation and axis patterning in the early mouse embryo. Nat Rev Mol Cell Biol 10: 91-103.
19. Carmeliet P and Jain RK (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473: 298-307.
20. Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, et al. (2012). RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 15: 727-744.
21. Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS, et al. (2008). Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res 78: 333-340.
22. Horst AK, Ito WD, Dabelstein J, Schumacher U, Sander H, Turbide C, et al. (2006). Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 116: 1596-1605.
23. Müller MM, Singer BB, Klaile E, Obrink B and Lucka L (2005). Transmembrane CEACAM1 affects integrin-dependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 105: 3925-3934.
24. Varu VN, Hogg ME and Kibbe MR (2010). Critical limb ischemia. J Vasc Surg 51: 230-241.
25. Khazaei M, Moien-Afshari F and Laher I (2008). Vascular endothelial function in health and diseases. Pathophysiology 15: 49-67.
26. Choi BJ, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW, et al. (2013). Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J 34: 2047-2054.
27. Brittan M, Hunter A, Boulberdaa M, Fujisawa T, Skinner EM, Shah AS, et al. (2015). Impaired vascular function and repair in patients with premature coronary artery disease. Eur J Prev Cardiol 22: 1557-1566.
28. Liu F, Walmsley M, Rodaway A and Patient R (2008). Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol 18: 1234-1240.
29. Miano JM and Long X (2015). The short and long of noncoding sequences in the control of vascular cell phenotypes. Cell Mol Life Sci 72: 3457-3488.
30. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M, et al. (2008). Mesp1 coordinately regulates cardiovascular fate restriction and epithelialmesenchymal transition in differentiating ESCs. Cell Stem Cell 3: 55-68.
31. Moore R, Cai KQ, Escudero DO and Xu XX (2009). Cell adhesive affinity does not dictate primitive endoderm segregation and positioning during murine embryoid body formation. Genesis 47: 579-589.
32. Zeng D, Ou DB, Wei T, Ding L, Liu XT, Hu XL, et al. (2013). Collagen/?(1) integrin interaction is required for embryoid body formation during cardiogenesis from murine induced pluripotent stem cells. BMC Cell Biol 14: 5.
33. Hwang YS, Chung BG, Ortmann D, Hattori N, Moeller HC and Khademhosseini A (2009). Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci USA 106: 16978-16983.
34. Evans SM, Yelon D, Conlon FL and Kirby ML (2010). Myocardial lineage development. Circ Res 107: 1428-1444.
35. Real PJ, Ligero G, Ayllon V, Ramos-Mejia V, Bueno C, Gutierrez-Aranda I, et al. (2012). SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol Ther 20: 1443-1453.
36. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V and Lacaud G (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 457: 892-895.
37. Oettgen P (2006). Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 99: 1159-1166.
38. Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q, et al. (2014). Regulation of lncRNA expression. Cell Mol Biol Lett 19: 561-575.
39. Pimanda JE, Ottersbach K, Knezevic K, Kinston S, Chan WY, Wilson NK, et al. (2007). Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc Natl Acad Sci USA 104: 17692-17697.
40. Wang J, Liu X, Wu H,, et al. (2010). CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 38: 5366-5383.
41. Clark MB, Johnston RL, Inostroza-Ponta M, Fox AH, Fortini E, Moscato P, et al. (2012). Genome-wide analysis of long noncoding RNA stability. Genome Res 22: 885-898.
42. Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD and Virmani R (2012). The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol 9: 439-453.
43. Santulli G, Wronska A, Uryu K, Diacovo TG, Gao M, Marx SO, et al. (2014). A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124: 4102-4114.
44. Song X, Shan D, Chen J and Jing Q (2014). miRNAs and lncRNAs in vascular injury and remodeling. Sci China Life Sci 57: 826-835.